http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2011106300-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-3211 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-306 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-67 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-662 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-655345 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-66 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-675 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-59 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-4816 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-3241 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-303 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-301 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-405 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-30 |
| filingDate | 2009-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2012-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2011106300-A |
| titleOfInvention | AMINOPHOSPHIC ACID DERIVATIVES FOR PAIN TREATMENT |
| abstract | 1. The compound of General formula (I):! ! or its pharmaceutically acceptable salt, where:! - R1 represents a group -C (= O) -O-C (R8) (R9) -OC (= O) -R10, where! - R8 and R9 independently represent a hydrogen atom or an alkyl, aryl, arylalkyl, cycloalkyl, cycloheteroalkyl, heteroalkyl, heteroaryl or heteroarylalkyl group; or ! - (R8 and R9) form, together with the carbon atom carrying them, a saturated hydrocarbon ring with 5 or 6 bonds; ! - and R10 represents an alkyl, aryl, arylalkyl, cycloalkyl, cycloheteroalkyl, heteroalkyl, heteroaryl or heteroarylalkyl group; ! - R2 is:! - a normal or branched, saturated or unsaturated hydrocarbon chain containing from 1 to 6 carbon atoms, and optionally substituted! - a group of OR11, SR11 or SOR11, where R11 represents a hydrogen atom, a benzyl group or a straight or branched, saturated or unsaturated hydrocarbon chain containing from 1 to 4 carbon atoms; ! an amino group; or ! phenyl optionally substituted with one or many halogen atoms such as fluorine; ! an aryl or heteroaryl group, preferably phenyl, optionally substituted with one or more halogen atoms such as fluorine; ! - a methylene group substituted by a saturated or aromatic heterocycle with 5 or 6 bonds, containing one or many heteroatoms selected from sulfur and nitrogen, optionally oxidized in the N-oxide or S-oxide form; ! - R3 represents a hydrogen atom or a group having the formula —C (R12) (R13) —OC (= O) —R14, where! - R12 and R13 are independently a hydrogen atom or an alkyl |
| priorityDate | 2008-07-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 83.